Application segmentation drives the bulk of the VNA & PACS market, reflecting the clinical domains that generate the highest imaging volumes. Radiology remains the dominant segment, accounting for roughly 45 % of revenue, as hospitals and imaging centers rely on VNA & PACS to store, retrieve, and share multi‑modality studies. Cardiology follows with an estimated 20 % share, propelled by the surge in echocardiography, CT‑angiography, and AI‑enhanced cardiac analysis that demand rapid, cross‑platform access. Oncology contributes about 15 % as precision‑medicine protocols require longitudinal imaging data across modalities, making robust VNA capabilities essential for treatment planning. Neurology represents roughly 10 % of the market, driven by neuro‑imaging workflows that benefit from seamless integration of MRI, PET, and functional studies. The residual 10 % falls under Other applications—such as orthopedics, gastroenterology, and veterinary imaging—where niche imaging volumes still justify VNA & PACS investments. This VNA & PACS segmentation by application underpins the overall market size, with each domain’s imaging workload directly scaling storage, networking, and analytics expenditures.